Copy and paste this code to insert a reference to this article in your
blog or online community profile:
 
 
Will Display Like this:
 
Utilizing Virtual Screening and Structure-Based Drug Design to Repurpose Approved Medications as Possible Inhibitors of the 3CL-Protease of the SARS-Cov-2
J Cell Mol Pharmacol 2022,6,135. 6:5, (2022)
https://doi.org/10.4172/jcmp.1000135